Literature DB >> 11755084

The E. coli alpha-hemolysin secretion system and its use in vaccine development.

Ivaylo Gentschev1, Guido Dietrich, Werner Goebel.   

Abstract

Many Gram-negative bacteria use a type I secretion system to translocate proteins, including pore-forming toxins, proteases, lipases and S-layer proteins, across both the inner and outer membranes into the extracellular surroundings. The Escherichia coli alpha-hemolysin (HlyA) secretion system is the prototypical and best characterized type I secretion system. The structure and function of the components of the HlyA secretion apparatus, HlyB, HlyD and TolC, have been studied in great detail. The functional characteristics of this secretion system enable it to be used in a variety of different applications, including the presentation of heterologous antigens in live-attenuated bacterial vaccines. Such vaccines can be an effective delivery system for heterologous antigens, and the use of a type I secretion system allows the antigens to be actively exported from the cytoplasm of the bacterial carrier rather than only becoming accessible to the host immune system after bacterial disintegration.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11755084     DOI: 10.1016/s0966-842x(01)02259-4

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  51 in total

Review 1.  Enteric pathogens as vaccine vectors for foreign antigen delivery.

Authors:  Camille N Kotton; Elizabeth L Hohmann
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

2.  Ion permeation through the alpha-hemolysin channel: theoretical studies based on Brownian dynamics and Poisson-Nernst-Plank electrodiffusion theory.

Authors:  Sergei Yu Noskov; Wonpil Im; Benoît Roux
Journal:  Biophys J       Date:  2004-10       Impact factor: 4.033

3.  Characterization of a novel microcin that kills enterohemorrhagic Escherichia coli O157:H7 and O26.

Authors:  Lauren J Eberhart; James R Deringer; Kelly A Brayton; Ashish A Sawant; Thomas E Besser; Douglas R Call
Journal:  Appl Environ Microbiol       Date:  2012-07-06       Impact factor: 4.792

4.  TdeA, a TolC-like protein required for toxin and drug export in Aggregatibacter (Actinobacillus) actinomycetemcomitans.

Authors:  Juan A Crosby; Scott C Kachlany
Journal:  Gene       Date:  2006-10-17       Impact factor: 3.688

5.  Characterization of a resistance-nodulation-cell division transporter system associated with the syr-syp genomic island of Pseudomonas syringae pv. syringae.

Authors:  Hyojeung Kang; Dennis C Gross
Journal:  Appl Environ Microbiol       Date:  2005-09       Impact factor: 4.792

Review 6.  Type V protein secretion pathway: the autotransporter story.

Authors:  Ian R Henderson; Fernando Navarro-Garcia; Mickaël Desvaux; Rachel C Fernandez; Dlawer Ala'Aldeen
Journal:  Microbiol Mol Biol Rev       Date:  2004-12       Impact factor: 11.056

7.  Antibodies against hemolysin and cytotoxic necrotizing factor type 1 (CNF1) reduce bladder inflammation in a mouse model of urinary tract infection with toxigenic uropathogenic Escherichia coli.

Authors:  Mark A Smith; Rebecca A Weingarten; Lisa M Russo; Christy L Ventura; Alison D O'Brien
Journal:  Infect Immun       Date:  2015-02-09       Impact factor: 3.441

8.  The rate of folding dictates substrate secretion by the Escherichia coli hemolysin type 1 secretion system.

Authors:  Patrick J Bakkes; Stefan Jenewein; Sander H J Smits; I Barry Holland; Lutz Schmitt
Journal:  J Biol Chem       Date:  2010-10-22       Impact factor: 5.157

Review 9.  Oral and intestinal bacterial exotoxins: Potential linked to carcinogenesis.

Authors:  Matthew Silbergleit; Adrian A Vasquez; Carol J Miller; Jun Sun; Ikuko Kato
Journal:  Prog Mol Biol Transl Sci       Date:  2020-04-09       Impact factor: 3.622

10.  Enhancing functional expression of heterologous lipase B in Escherichia coli by extracellular secretion.

Authors:  Niju Narayanan; Manal Khan; C Perry Chou
Journal:  J Ind Microbiol Biotechnol       Date:  2009-12-29       Impact factor: 3.346

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.